To determine whether Aβ treatment upregulates the transcription of IGFBP-3, we treated human astrocytoma cells (H4 cells) with 1 μM Aβ1–42 for 24 h. This evidence concerns the gene IGFBP3 and astrocytoma (excluding glioblastoma).